Antibody Titer, Erythrocytes
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Monitoring antibody levels during pregnancy to help assess the risk of hemolytic disease of the newborn
Reflex Tests Lists test(s) that may or may not be performed, at an additional charge, depending on the result and interpretation of the initial test(s)
|Test ID||Reporting Name||Available Separately||Always Performed|
|ABID2||Antibody Identification, RBC||Yes||No|
|DCTM||Direct Coombs, B||Yes||No|
|MDCC3||Monospecific Direct Coombs C3, B||Yes||No|
|MDCG||Monospecific Direct Coombs IgG, B||Yes||No|
|SPAG||Special Red Cell Ag Typing||Yes||No|
Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.
The initial test performed is an antibody identification. If the antibody problem identified is not relevant in hemolytic disease of the newborn, or if titrations are not helpful, the titer will be cancelled and will be replaced by the antibody identification test. Depending upon the antibody identification results, additional tests, ie, monospecific direct Coombs, antibody elution, antibody absorption, and red cell antigen typing may be added and charged. A consultation service is offered, at no charge, regarding the clinical relevance of red cell antibodies.
ABID2/8988: Ten-Cell Panel
ABA/9389, SPAG/8980: Standard Blood Bank Techniques
ABEL/9390: Acid-EDTA Elution/Other standard methods may be used in difficult cases.
DCTM/9008, MDCG/86880, MDCC3/87855: Direct Antiglobulin Test
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
Lewis A Antibody Titer
RBC Antibody Titer
Rh (Rhesus) Titer